Cystic fibrosis, genetics, and DNA technology

Curr Opin Obstet Gynecol. 1991 Apr;3(2):235-41.

Abstract

Advances in molecular genetics are leading to changes in practice that have a direct impact on the obstetrician and gynecologist. New techniques of prenatal screening, diagnosis, and potentially therapy are rapidly evolving. Recent developments in cystic fibrosis, preimplantation genetics, fragile X syndrome, neurofibromatosis, muscular dystrophy, and Marfan syndrome are discussed.

Publication types

  • Review

MeSH terms

  • Cystic Fibrosis / diagnosis*
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / therapy
  • Fetal Diseases / diagnosis*
  • Fetal Diseases / genetics
  • Fetal Diseases / therapy
  • Fragile X Syndrome / diagnosis
  • Fragile X Syndrome / genetics
  • Genetic Markers
  • Humans
  • Marfan Syndrome / diagnosis
  • Marfan Syndrome / genetics
  • Molecular Biology
  • Muscular Dystrophies / diagnosis
  • Muscular Dystrophies / genetics
  • Neurofibromatosis 1 / diagnosis
  • Neurofibromatosis 1 / genetics
  • Prenatal Diagnosis*

Substances

  • Genetic Markers